#1И AboM 19beM BaulчboM MedPlus+ AzulibaM INVESTOR PRESENTATION ChaulaboM ELUPIO KAMOR N AUGUST 2022 ZELLIMAO KAMCY MedPlus+#2( ) MedPlus+#3Accelerated store expansion Stable operating performance of mature stores (>12m) % % Strong unit economics % Engine to pr % Diagnostics pilot on track Outlook & MedPlus+#4Jo % % % % % % % % % % % % % Pharmacy Retail Food & Grocery Jewellery & Watches Apparel & Accessories Footwear Consumer Electronics %#5+ + + MedPlus+#6370 651 553 350 621 106 328 + % + ( % ) ( ) MedPlus+#7Over 605 products covering Chronic, Acute, OTC & Other Pharmaceutical products ylephrine Hochloride and Chophenianine Meste Syrup COLDLARC WYNACIO WYNCODRYL Trinke Controlad Release Tablets 2.6 mo AF Over 280 products covering, packaged food, baked goods, dry goods, cleaning products, cosmetics and toiletries DOSTAD nicowyn Nicotine Gum Stop smoking aid AquaRed BEE - 1600 Reve + CORN MedPlus+#8+ MedPlus+#9* 9,937m Revenue % % ) 232 Store Net Additions • ( ) 2,103m Gross Margin % ) (90 % % Stores > 12 months ( ) % % % *292m Pharmacy Operating EBITDA % * 202m Operating Cash Flow % 20% Oncer Orches B MedPlus medplusmart.com Quality Chemists&Druggist 20% बचत 24 Full FOR HOME DELIVERY 20. COUNT NERAL PRODUCTS MedPlus+#10Q1FY22 Gross < Margin % Q2FY22 Q3FY22 ( ) זיון װױױ % Margin Operating EBITDA Pharmacy ► % % % % % Q4FY22 % % % % Q1FY23 Q1FY22 Q2FY22 Operating ► % EBITDA Margin % Q3FY22 Q4FY22 Q1FY23 % % % MedPlus+#11We are present in key 7 states, accounting for c.38.4% of India's population². The key urban centers are: Bangalore, Chennai, Hyderabad, Kolkata, Mumbai, Nagpur, Pune, Visakhapatnam We are present in 374 cities 901 274 458 ( ) GeoNam + 324 370 553 350 651 621 328 106 MedPlus+#12We opened 252 stores in Q1FY23. There were 20 closures 19 5 20 G-GeoNam + 10 ( ) MedPlus+#13Maintaining an increasing pace of store openings Share of stores less than 24 months age is increasing Stores ► % % % % % % % % % % % do % % % % % MedPlus+#14% % % % Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 % Q1FY22 Q2FY22 % + % % % % Q3FY22 Q4FY22 Q1FY23 % % % % % Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 MedPlus+#15% % % % % % % % % % % % % % Trend of % increasing share % % % % % % % 200 % from Private % % Label continues % % % 10 % do % Maintaining trend % % % % % % % % % % of growth beyond Metro and Tier- One + MedPlus+#16% % % Our online presence grows % % on the back of % our rapid store additions % 200 % % % % % % % % % % Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 ( ) Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 MedPlus+#17Q1FY22 Q4FY22 Q1FY23 Q1FY23 vs. Q1FY22 (yoy) Q1FY23 vs. Q4FY22(qoq) % % % % Gross Margin 2,115.0 2,059.0 2,103.1 22.1% 21.3% 21.2% ( ) ( ) ( ) % % Operating EBITDA 704.5 295.2 221.7 % % 7.4% 3.1% 2.2% % % ( ) ( ) ( ) % % % % 1,007.3 653.2 627.7 % % 10.5% 6.8% 6.3% & ( ) ( ) ( ) % % ( ) ( ) ( ) % % % % PAT 463.6 114.3 36.8 % % 4.9% 1.2% 0.4% MedPlus+#18Q4FY22 Q1FY23 Pharmacy Retail Diagnostic Others Total Pharmacy Retail Diagnostic Others Total Operating EBITDA 396.6 -76.0 % % & -25.3 295.2 292.3 -51.9 -18.7 221.7 % % % % % 653.3 % 627.7 % MedPlus+#19Assets Total Non Current Assets (A) Mar-22 Jun-22 9.623.4 10,606.2 Total Current Assets (B) Total Assets (A + B) Equity and Liabilities 16,317.1 25,940.5 14,850.3 25,456.5 Total Equity and Liabilities 25,940.5 25,456.5 MedPlus+#20NWC (days) ► 115 days inventory (on Year 1 stores revenue) 39 days inventory (on revenue of stores older than 12 months) Q1FY22 Q2FY22 Q3FY22 Q4FY Q1FY#213,000 2,500 2,000 1,500 1,000 625 500 0 -500 -1,000 + & + + -387 -36 -402 34 -372 -8 -546 MedPlus+#22A. Board and key management B. Glossary MedPlus+#23Gangadi Madhukar Reddy Founded MedPlus and has led it since inception Anish Kumar Saraf MD at Warburg Pincus India Atul Gupta Investment partner at Premji Invest Dr. Bhaskar Reddy COO-Outlet Operations Dr. Surendranath Mantena COO-MedPlus Mart Hiroo Mirchandani Senior business leader in healthcare and consumer sectors Madhavan Ganesan Senior business leader. Over 3 decades covering retail and technology Murali Sivaraman Senior business leader. Over 3 decades in India and international markets Venugopal Sirripuram Chief Technology Officer, Optival Kandasamy Vairaperumal Head Supply Chain, Optival O Managing Director & CEO Independent Non-Executive Director O Non-Executive Director Lakshman Kandarpa Chief Retail Officer, Optival Chetan Dikshit Chief Strategy Officer MedPlus+#24Term ( ) ( ) ( ) + Description ( ) ( ) ) + ) ) ( ) ( ( ) ( ) + ( + ( ) MedPlus+#25月 ARTH И baM MbaM aulabaM zulbaM Bruficoll MEDPLUS HEALTH SERVICES LIMITED COMPANY SECRETARY INVESTOR RELATIONS MEDIA AND PRESS ENQUIRIES